␤-Site amyloid precursor protein-cleaving enzyme 1 (BACE1)-the neuronal ␤-secretase responsible for producing ␤-amyloid (A␤) peptides-emerged as one of the key therapeutic targets of Alzheimer's disease (AD). Although complete ablation of the BACE1 gene prevents A␤ formation, we reported that BACE1 knock-out mice display severe presynaptic deficits at mossy fiber (MF)-to-CA3 synapses in the hippocampus, a major locus of BACE1 expression. We also found that the deficits are likely due to abnormal presynaptic Ca 2ϩ regulation. Cholinergic system has been implicated in AD, in some cases involving Ca 2ϩ -permeable ␣7-nicotinic acetylcholine receptors (nAChRs). Here we report that brief application of nicotine, via ␣7-nAChRs, can restore MF long-term potentiation in BACE1 knock-outs. Our data suggest that activating ␣7-nAChRs can recover the presynaptic deficits in BACE1 knock-outs.
Introduction
Alzheimer's disease (AD) is the most prevalent form of senile dementia with limited treatment options (Vassar et al., 2009) . A current hypothesis of AD states that overexpression of amyloid-␤ (A␤) peptide initiates a cascade of events leading to its pathology (Walsh and Selkoe, 2007) . ␤-Site amyloid precursor proteincleaving enzyme 1 (BACE1), the neuronal ␤-secretase, is the first enzyme involved in the sequential cleavage of amyloid precursor proteins (APPs) to produce A␤ (Vassar et al., 2009) . High levels of BACE1 are correlated with an increase in A␤ in sporadic AD O'Connor et al., 2008) . Knocking out BACE1 abolishes A␤ peptide production (Cai et al., 2001) , prevents amyloid plaque deposition, and rescues memory deficits in APP transgenic lines (Luo et al., 2003; Ohno et al., 2004) . These observations encourage the development of BACE1 inhibition strategies for AD treatment. However, studies revealed that BACE1 knock-outs (KOs) display behavior deficits (Harrison et al., 2003; Laird et al., 2005; Savonenko et al., 2008) and specific synaptic dysfunctions in the CA1 of hippocampus (Laird et al., 2005) . Moreover, at the MF-to-CA3 synapses, where high levels of BACE1 are expressed (Laird et al., 2005) , BACE1 KOs display severe presynaptic dysfunctions (Wang et al., 2008) . The deficits include a reduction in presynaptic release and an absence of mossy fiber long-term potentiation (mfLTP), which are due to abnormal presynaptic Ca 2ϩ signaling (Wang et al., 2008) . These studies caution against the use of BACE1 inhibitors as a practical treatment for AD.
Cholinergic system modulates neurotransmitter release from glutamatergic and GABAergic terminals via the action of nicotinic acetylcholine receptors (nAChRs) (Gray et al., 1996; Radcliffe et al., 1999; Giocomo and Hasselmo, 2005; Jiang and Role, 2008; Bancila et al., 2009) . Among them, ␣7-nAChR is a Ca 2ϩ -permeable homopentameric ion channel highly expressed in the hippocampus and cerebral cortex (Séguéla et al., 1993) . Several studies have linked ␣7-nAChR with neurodegenerative disorders, including AD (Perry et al., 2000) . We present data that activating ␣7-nAChRs, by nicotine (Nic) or a specific agonist, PNU282987, can restore presynaptic function and mfLTP in BACE1 KOs via recruiting calcium-induced calcium release (CICR).
Materials and Methods
Animals. All mice used (BACE1 ϩ/ϩ and Ϫ/Ϫ) were derived from heterozygous breeders (ϩ/Ϫ) as described previously (Laird et al., 2005) . The Institutional Animal Care and Use Committees of both University of Maryland and Johns Hopkins University approved all procedures involving animals.
Electrophysiological recordings. Hippocampal slices (400 m thick) were prepared from adult (3-6 months old) male BACE1 KOs and wild types (WTs) as previously described (Wang et al., 2008) . Briefly, hippocampi were sliced in ice-cold dissection buffer (in mM: 212.7 sucrose, 2.6 KCl, 1.23 NaH 2 PO 4 , 26 NaHCO 3 , 10 dextrose, 3 MgCl 2 , and 1 CaCl 2 ; 5% CO 2 /95% O 2 ). Recordings were done in a submersion-type chamber perfused with artificial CSF (ACSF, in mM: 124 NaCl, 5 KCl, 1.25 NaH 2 PO 4 , 26 NaHCO 3 , 10 dextrose, 1.5 MgCl 2 , and 2.5 CaCl 2 ; 5% CO 2 / 95% O 2 , 29.5-30.5°C, 2 ml/min). Synaptic responses were evoked through glass bipolar stimulating electrodes placed in the dentate granule cell layer to activate MFs with pulse duration of 0.2 ms (at 0.067 Hz), and recorded extracellularly in the stratum lucidum of CA3. Paired-pulse facilitation (PPF) was measured at 25, 50, 100, 200, 400, 1000, and 2000 ms interstimulus intervals (ISIs). To induce mfLTP, three trains of 100 Hz (1 s) stimuli were given at 20 s intervals. We used ␣7-nAChR agonists (Ϫ)-nicotine (Sigma-Aldrich) and PNU282987 (Tocris Bioscience), and an antagonist ␣-bungarotoxin (Tocris Bioscience). To block intracellular Ca 2ϩ release, ruthenium red (Tocris Bioscience) or ryanodine (Tocris Bioscience) was applied. All experiments were done in the presence of 100 M D,L-2-amino-5-phosphonovaleric acid (D,L-APV) (SigmaAldrich) to isolate the presynaptic NMDAR-independent mfLTP (Nicoll and Schmitz, 2005) . At the end of each experiment, 1 M (2S,2ЈR,3ЈR)-2-(2Ј,3Ј-dicarboxycyclopropyl)glycine (DCG-IV) (Tocris Bioscience) was added, and responses blocked by Ն80% were taken to be MF inputs. Field potential slopes were measured, and data are expressed as mean Ϯ SEM.
Results

Nicotine restores presynaptic function at MF synapses in BACE1 KOs
We first examined the effect of nicotine on the presynaptic function of MFs in BACE1 KOs by measuring PPF. The results showed that nicotine decreased PPF ratio in a dose-dependent manner at 25 and 50 ms ISIs in KOs (n ϭ 7 slices/3 mice; ANOVA: p Ͻ 0.05) (Fig. 1 A) , and 10 M was the lowest concentration that significantly decreased PPF ratio in both genotypes (KO: control ϭ 4.81 Ϯ 0.16, nicotine ϭ 4.05 Ϯ 0.22, n ϭ 15 slices/10 mice, paired t test: p Ͻ 0.001; WT: control ϭ 3.77 Ϯ 0.43, nicotine ϭ 3.50 Ϯ 0.40, n ϭ 10 slices/9 mice, paired t test: p Ͻ 0.001) (Fig. 1 B) . We previously showed that BACE1 KOs display a significant increase in PPF ratio at MF synapses indicating a reduction in presynaptic release (Wang et al., 2008) . Nicotine at 10 M concentration decreased the PPF ratio of KOs to a similar level of WTs (t test: p ϭ 0.57) without affecting synaptic transmission in either genotype (KO: 100 Ϯ 1% of baseline at 20 min after nicotine, n ϭ 15 slices/10 mice; paired t test: p ϭ 0.97; WT: 99 Ϯ 1%, n ϭ 10 slices/9 mice; paired t test: p ϭ 0.54) (Fig. 1 B) . These results suggest that 10 M nicotine reverses PPF deficits in BACE1 KOs without affecting synaptic strength. Therefore, 10 M nicotine was used in subsequent experiments.
Nicotine rescues mfLTP in BACE1 KOs without affecting mfLTP in WTs Consistent with our previous results, KOs lacked mfLTP under control conditions, but 10 M nicotine applied during the whole duration of the experiment restored mfLTP [control: 95 Ϯ 4% at 1 h after high-frequency stimulation (HFS), n ϭ 6 slices/4 mice; nicotine: 133 Ϯ 7%, n ϭ 8 slices/7 mice; t test: p Ͻ 0.001] (Fig.  2 A) . Nicotine-induced rescue of mfLTP was accompanied by a significant decrease in PPF ratio (50 ms ISI; baseline: 4.36 Ϯ 0.26, 1 h after HFS: 3.01 Ϯ 0.27, paired t test: p Ͻ 0.001) ( Fig. 2 A, inset), suggesting presynaptic expression. Interestingly, 10 M nicotine did not alter the magnitude of mfLTP in WTs (control: 148 Ϯ 3% at 1 h after HFS, n ϭ 5 slices/3 mice; nicotine: 144 Ϯ 6%, n ϭ 7 slices/6 mice; t test: p ϭ 0.52) (Fig. 2 B) .
To investigate whether nicotine affects the induction mechanisms of mfLTP, we transiently applied nicotine for 10 min before and during the HFS. KOs displayed significant mfLTP, which was similar in magnitude with that evoked in WTs (KO ϭ 147 Ϯ 2% at 1 h after HFS, n ϭ 8 slices/5 mice, paired t test: p Ͻ 0.001; WT: 157 Ϯ 8%, n ϭ 8 slices/5 mice, paired t test: p Ͻ 0.001) (Fig. 2C,D) . Furthermore, mfLTP was accompanied by a significant decrease in PPF ratio (50 ms ISI) in both genotypes (WT: baseline ϭ 3.66 Ϯ 0.16, 1 h after HFS ϭ 2.55 Ϯ 0.21, paired t test: p Ͻ 0.001; KO: baseline ϭ 4.59 Ϯ 0.35, 1 h after HFS ϭ 2.95 Ϯ 0.33, paired t test: p Ͻ 0.001) (Fig. 2C ,D, insets), consistent with an increase in presynaptic release. These results demonstrate that nicotine specifically rescues the induction mechanisms of mfLTP in BACE1 KOs.
Nicotine-induced rescue of mfLTP in BACE1 KOs is mediated by ␣7-nAChRs
We showed that presynaptic dysfunction of MF synapses in BACE1 KOs is at the level of Ca 2ϩ regulation (Wang et al., 2008) . To determine whether nicotine acts via the Ca 2ϩ -permeable ␣7-nAChRs, we used a specific agonist, PNU282987 (Bodnar et al., 2005) . A brief application of PNU282987 (500 nM, 10 min) before and during HFS recovered mfLTP in KOs (1 h after HFS: 167 Ϯ 19%, n ϭ 8 slices/5 mice; paired t test: p Ͻ 0.05) (Fig. 3A ) for up to 2 h (supplemental Fig. 1 , available at www.jneurosci.org as supplemental material). Furthermore, PPF ratio decreased significantly after PNU282987 application and further by LTP induction (baseline: 6.29 Ϯ 0.77, ϩPNU282987: 5.81 Ϯ 0.76, 1 h after HFS: 4.80 Ϯ 0.69) (Fig. 3A, inset) . PNU282987 alone did not produce changes in synaptic strength (1 h after PNU282987: 105 Ϯ 4%, n ϭ 4 slices/2 mice; paired t test: p ϭ 0.30) (Fig. 3A) .
To further test whether nicotine-induced rescue of mfLTP was mediated by ␣7-nAChRs, we applied 100 nM ␣-bungarotoxin (␣BTX), a selective antagonist. ␣BTX abolished the effect of nicotine on mfLTP (1 h after HFS: 105 Ϯ 4%, n ϭ 10 slices/6 mice; paired t test: p Ͼ 0.05) (Fig. 3B ) and PPF ratio (␣BTX: 5.22 Ϯ 0.65, ␣BTXϩnicotine: 5.17 Ϯ 0.65, 1 h after HFS: 5.19 Ϯ 0.73) (Fig. 3B, inset) in KOs. Application of ␣BTX and nicotine in the absence of HFS did not alter synaptic transmission (1 h after ␣BTXϩNic: 100 Ϯ 1%, n ϭ 4 slices/2 mice; paired t test: p ϭ 0.86) (Fig. 3B) . These results suggest that nicotine-induced rescue of presynaptic deficits in BACE1 KOs is mediated by ␣7-nAChRs.
Finally, we tested whether ␣7-nAChRs are required for mfLTP in WTs. A brief application of ␣BTX (10 min) before and during HFS failed to block mfLTP in WTs (1 h after HFS: 148 Ϯ 6%, n ϭ 9 slices/7 mice; paired t test: p Ͻ 0.001) (Fig. 3C ). This indicates that activation of ␣7-nAChRs is not necessary for mfLTP induction in WTs, hence the rescue of mfLTP in KOs by ␣7-nAChR activation is probably via recruitment of an alternative pathway not normally used in WTs.
CICR is involved in nicotine-induced rescue of mfLTP in BACE1 KOs
Activation of ␣7-nAChRs enhances CICR from ryanodine-sensitive Ca 2ϩ stores (Sharma and Vijayaraghavan, 2003; Sharma et al., 2008) . To investigate whether CICR is also involved in nicotine-induced rescue of mfLTP in KOs, we used 20 M ruthenium red (RR) or 100 M ryanodine (Ryan), which are blockers of ryanodine-sensitive stores. Both drugs completely abolished nicotineinduced recovery of PPF ratio [RR: 5.00 Ϯ 0.69, RRϩNic: 4.97 Ϯ 0.70, 1 h after HFS: 4.62 Ϯ 0.74 (Fig. 4 A, inset) ; Ryan: 5.01 Ϯ 0.20, RyanϩNic: 5.03 Ϯ 0.23, 1 h after HFS: 4.93 Ϯ 0.25] and mfLTP (1 h after RRϩNic: 91 Ϯ 5%, n ϭ 9 slices/5 mice; paired t test: p ϭ 0.18; 1 h after RyanϩNic: 100 Ϯ 2%, n ϭ 6 slices/3 mice; paired t test: p ϭ 0.66) (Fig. 4 A) in KOs without influencing basal synaptic transmission. mfLTP was present in WTs treated with RR (1 h after HFS: 124 Ϯ 5%, n ϭ 9 slices/5 mice; paired t test: p Ͻ 0.01) (Fig. 4 B) , but was significantly less than that in control WTs (t test: p Ͻ 0.01), suggesting that CICRs are only partially involved.
Discussion
We found that nicotine restores PPF and LTP at MF-to-CA3 synapses in BACE1 KOs. The nicotine effect was mimicked by ␣7-nAChR-specific agonist PNU282987, and blocked by ␣7-nAChR antagonist ␣BTX. We have evidence that nicotine acts via recruiting CICR. These results suggest nicotine and ␣7-nAChR agonists as potential pharmacological means to circumvent the presynaptic deficits caused by BACE1 inhibition. mfLTP is presynaptically expressed, requiring an increase in presynaptic Ca 2ϩ and a subsequent activation of cAMP-PKA signaling pathway (Nicoll and Schmitz, 2005) . We previously demonstrated that presynaptic dysfunction seen in BACE1 KOs is at the level of Ca 2ϩ regulation, but the downstream PKA signaling is intact (Wang et al., 2008) . These results predict that restoring presynaptic Ca 2ϩ signaling should recover mfLTP in BACE1 KOs. Presynaptic ␣7-nAChR elevates the intracellular concentration of free Ca 2ϩ (Vijayaraghavan et al., 1992) and enhances glutamate release at MF terminals (Sharma and Vijayaraghavan, 2003; Sharma et al., 2008; Bancila et al., 2009 ). The nicotineinduced rescue of PPF and mfLTP without much effect on basal synaptic transmission is likely via the recruitment of CICR, which is known to preferentially amplify use-dependent release (Shimizu et al., 2008 ). Short-term presynaptic plasticity, including PPF, does not depend on CICR at MF terminals (Carter et al., 2002) . Consistent with this, inhibiting CICRs in WTs did not alter PPF ratio, but reduced mfLTP magnitude, which suggests that HFS recruits CICR. In the case of KOs, it is clear that the CICR triggered by ␣7-nAChR activation is needed to rescue mfLTP. Although we cannot rule out the possible involvement of ␣7-nAChRs on interneurons, the detection of ␣7-nAChR immunoreactivity in the MF input region (supplemental Fig. 2 , available at www.jneurosci.org as supplemental material) provides a substrate for ␣7-nAChR agonists to act on MF terminals. This is further corroborated by a recent electron microscopy study, which localized ␣7-nAChRs on MF terminals (Bancila et al., 2009) . Interestingly, the ␣7-nAChRs were present away from the active zone, suggesting an indirect regulation of presynaptic release.
It is known that ␣7-nAChRs can rapidly desensitize upon agonist binding in a dose-dependent manner (Peng et al., 1994) . Because nicotine-induced rescue of mfLTP was blocked by ␣BTX, we suspect residual ␣7-nAChR activity even with the prolonged application of nicotine used in our study. Interestingly, the increase in glutamate release at MF terminals with ␣7-nAChR activation is rather slow and involves presynaptic Ca 2ϩ increase via CICR from internal stores (Sharma and Vijayaraghavan, 2003; Sharma et al., 2008) . In synaptosomes isolated from the prefrontal cortex, ␣7-nAChR agonist-induced glutamate release is dependent on CICR and a downstream activation of extracellular signal-regulated kinase (ERK) signaling (Dickinson et al., 2008) . These results suggest that presynaptic signaling of ␣7-nAChRs leading to glutamate release may outlast the initial activation of the receptor.
The regulation of ␣7-nAChRs has been implicated in the pathology of AD. There are studies reporting high-affinity binding between A␤42 and ␣7-nAChRs (Wang et al., 2000a,b) , which either inhibit (Guan et al., 2001; Liu et al., 2001; Pettit et al., 2001) or activate (Dineley et al., 2001 ) ␣7-nAChR signaling. It is possible that A␤42 may facilitate ␣7-nAChRs at low concentration, but may inhibit nAChRs when the burden of A␤ peptides increases (Dineley et al., 2001; Dougherty et al., 2003) . The concentration-dependent dual role of A␤42 is evident in a study showing that picomolar range of A␤42 facilitates, but nanomolar range abolishes, LTP in CA1 and learning via its action on ␣7-nAChRs (Puzzo et al., 2008) . It is unlikely that endogenous A␤42 acts in this manner to influence mfLTP, because blocking ␣7-nAChRs with ␣-BTX did not affect mfLTP in WTs. This result indirectly argues that the lack of mfLTP in BACE1 KOs may not be a strict consequence of lacking A␤. Interestingly, BACE1 has been found to regulate neuregulin-1 (NRG1) cleavage (Hu et al., 2006; Willem et al., 2006) , and indeed this process is affected in BACE1 KOs (Savonenko et al., 2008) . NRG1 is critically involved in maintaining surface expression of presynaptic ␣7-nAChRs Zhong et al., 2008) . However, in isolated CA3 slices, we did not see a change in the total or cell surface levels of ␣7-nAChRs and NRG1 in the KOs (supplemental Fig. 3 , available at www.jneurosci.org as supplemental material). Furthermore, our ability to rescue mfLTP in KOs with ␣7-nAChR agonists suggests sufficient presence of functional ␣7-nAChRs.
Several potential methods are being developed to overcome dysfunctions caused by complete BACE1 inhibition, such as partial BACE1 inhibition (Vassar et al., 2009 ). While our results might reflect a developmental loss of BACE1, they suggest that combining ␣7-nAChR agonists with BACE1 inhibitors may be another alternative.
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Supplementary Methods
Immunohistochemistry and confocal imaging
Hippocampal slices (300-µm-thick) 
Steady-state surface biotinylation
Hippocampal slices (400 µm thick) were prepared as described above, and the CA3 region was isolated. After 30 min recovery at room temperature, the isolated CA3 slices were transferred to 30°C for additional 30 min recovery. The slices were then transferred to ice-cold ACSF for 10 min, and subsequently to ice-cold ACSF containing 2 mg/ml biotin (EZ-Link Sulfo-NHS-Biotin, Pierce) saturated with 5% CO 2 /95% O 2 for 15 min. The slices were then washed in tris-buffered saline (TBS: 50 mM Tris, 0.9% NaCl, pH 7.4) containing 100 mM glycine (5 times, 1 min each) before homogenized in icecold 0.2% SDS/1% Triton X-100 IPB (20 mM Na 3 PO 4 , 150 mM NaCl, 10 mM EDTA, 10 mM EGTA, 10 mM Na 4 P 2 O 7 , 50 mM NaF, and 1 mM Na 3 VO 4 , pH 7.4; with 1 µM okadaic acid and 10 KIU/ml aprotinin) by ~30 gentle strokes using glass-teflon tissue homogenizers (Pyrex). The homogenates were centrifuged for 10 min at 13,200 × g, 4°C.
Protein concentration of the supernatant was measured and normalized to 2 mg/ml. Some of the supernatants were saved as inputs by adding gel sampling buffer and boiled for 5 min. 300 µg of each supernatant was mixed with neutravidin slurry [1:1 in 1% Triton X-100 IPB (TX-IPB)] and rotated overnight at 4°C. The neutravidin beads were isolated by brief centrifugation at 1,000 × g. Some of the supernatants were saved by adding gel sample buffer and boiled for 5 min. The neutravidin beads were washed 3 times with 1% TX-IPB, 3 times with 1% TX-IPB containing 500 mM NaCl, followed by 2 washes in 1% TX-IPB. The biotinylated surface proteins were then eluded from the neutravidin beads by boiling in gel sampling buffer for 5 min. The input (I, total homogenate), supernatant (S, intracellular fraction), and biotinylated samples (B, surface fraction) were run on the same gel, and processed for immunoblot analysis using α7-nAchR and actin antibodies. The band intensity in the input lanes and biotin lanes, which fell within the linear range, was quantified to calculate the % of total α7-nAchR on the surface for each sample.
Immunoblot analysis
SDS-PAGE gels were transferred to polyvinyl difluoride (PVDF) membranes (Immobilon TM , Millipore). The PVDF membrane blots were blocked for ~1 hr in blocking buffer (1% bovine serum albumin and 0.1% Tween-20 in phosphate buffered saline (PBS), pH 7.4), and subsequently incubated for 1-2 hrs in primary antibodies (Ab's) diluted in blocking buffer. After 5 x 5 min washes in blocking buffer, the blots were incubated for 1 hr in 2 nd Ab linked to Cy3 and Cy5. After washes, blots were scanned using Typhoon Trio (GE Health), and signals were quantified using Image Quant TL software (GE Health). The fluorescence intensity values for each band was then normalized to the average value of WT samples on the same blot to obtain the % of average WT values, which were compared across different experimental groups using unpaired Student's t-test. The biotinylation blots were also probed simultaneously with α7-nAchR and actin antibodies using the ECL plex system. The band intensities of biotinylated samples were normalized to that of the input lanes (total protein) to obtain the level of surface α7-nAchR as a % of total value.
